Rimas V. Lukas
Experienced in Spinal Tumor

Dr. Rimas V. Lukas

Hematology | Oncology
Northwestern Medical Group
675 N St Clair St Ste 20-100, Galter Pavilion, 
Chicago, IL 
Offers Telehealth
24 Years of Experience
Experienced in Spinal Tumor
Northwestern Medical Group
675 N St Clair St Ste 20-100, Galter Pavilion, 
Chicago, IL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Rimas Lukas is a Hematologist and an Oncologist in Chicago, Illinois. Dr. Lukas has been practicing medicine for over 24 years and is rated as an Experienced provider by MediFind in the treatment of Spinal Tumor. His top areas of expertise are Astrocytoma, Glioma, Glioblastoma, Brain Tumor, and Gastrostomy.

His clinical research consists of co-authoring 198 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Spinal Tumor.

Graduate Institution
Rush University Medical College, 2002.0
Residency
University of Chicago
Specialties
Hematology
Oncology
Licenses
Psychiatry & Neurology in IL
Board Certifications
American Board Of Psychiatry And Neurology - Neurology (Certified)
Hospital Affiliations
Northwestern Memorial Hospital
Northwestern Medicine Central Dupage Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

675 N St Clair St Ste 20-100, Galter Pavilion, Chicago, IL 60611
Call: 312-695-4360

Additional Areas of Focus

Dr. Lukas has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Metastatic Uveal Melanoma

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).
Enrollment Status: Completed
Publish Date: October 31, 2025
Intervention Type: Device, Other
Study Phase: Phase 3
Phase 1 / 2 Trial of Blood-brain Barrier Opening With an Implantable Ultrasound Device SonoCloud-9 and Treatment With Albumin-bound Paclitaxel and Carboplatin in Patients With Recurrent Glioblastoma
Phase 1 / 2 Trial of Blood-brain Barrier Opening With an Implantable Ultrasound Device SonoCloud-9 and Treatment With Albumin-bound Paclitaxel and Carboplatin in Patients With Recurrent Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: July 31, 2025
Intervention Type: Drug, Device
Study Drug: Chemotherapy, Albumin-Bound Paclitaxel
Study Phase: Phase 1/Phase 2
Combination of Checkpoint Inhibition and IDO1 Inhibition Together With Standard Radiotherapy or Chemoradiotherapy in Newly Diagnosed Glioblastoma. A Phase 1 Clinical and Translational Trial
Combination of Checkpoint Inhibition and IDO1 Inhibition Together With Standard Radiotherapy or Chemoradiotherapy in Newly Diagnosed Glioblastoma. A Phase 1 Clinical and Translational Trial
Enrollment Status: Active_not_recruiting
Publish Date: June 29, 2025
Intervention Type: Drug, Radiation
Study Drugs: BMS-986205, Nivolumab, Temozolomide
Study Phase: Phase 1
Phase III Trial of Stereotactic Radiosurgery (SRS) or Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) for Distant Brain Relapse With Brain Metastasis Velocity >/= 4 Brain Metastases/Year
Phase III Trial of Stereotactic Radiosurgery (SRS) or Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) for Distant Brain Relapse With Brain Metastasis Velocity >/= 4 Brain Metastases/Year
Enrollment Status: Terminated
Publish Date: June 06, 2025
Intervention Type: Other, Procedure, Drug, Radiation
Study Drug: Memantine
Study Phase: Phase 3
A Phase I Study of Ad-RTS-hIL-12, an Inducible Adenoviral Vector Engineered to Express hIL-12 in the Presence of the Activator Ligand Veledimex in Subjects With Recurrent or Progressive Glioblastoma or Grade III Malignant Glioma
A Phase I Study of Ad-RTS-hIL-12, an Inducible Adenoviral Vector Engineered to Express hIL-12 in the Presence of the Activator Ligand Veledimex in Subjects With Recurrent or Progressive Glioblastoma or Grade III Malignant Glioma
Enrollment Status: Completed
Publish Date: April 16, 2025
Intervention Type: Drug, Biological
Study Drugs: Ad-RTS-hIL-12, Veledimex
Study Phase: Phase 1
A Phase 3, Randomized, Controlled, Double-Arm, Open-Label, Multi-center Study of VB-111 Combined With Bevacizumab vs. Bevacizumab Monotherapy in Patients With Recurrent Glioblastoma
A Phase 3, Randomized, Controlled, Double-Arm, Open-Label, Multi-center Study of VB-111 Combined With Bevacizumab vs. Bevacizumab Monotherapy in Patients With Recurrent Glioblastoma
Enrollment Status: Completed
Publish Date: October 23, 2018
Intervention Type: Drug
Study Phase: Phase 3
View 5 Less Clinical Trials

196 Total Publications

Surgical Treatment of Brain Tumor-Related Epilepsy: Current and Emerging Strategies.
Surgical Treatment of Brain Tumor-Related Epilepsy: Current and Emerging Strategies.
Journal: Cancers
Published: October 06, 2025
View All 196 Publications
Similar Doctors
Experienced in Spinal Tumor
Dr. Gowri Ramadas
Hematology | Oncology
Experienced in Spinal Tumor
Dr. Gowri Ramadas
Hematology | Oncology

Northwest Cancer Centers PC

342 E 109th Ave, Northwest Cancer Ctr, 
Crown Point, IN 
 (35.9 miles away)
219-310-2550
Languages Spoken:
English
See accepted insurances

Gowri Ramadas is a Hematologist and an Oncologist in Crown Point, Indiana. Dr. Ramadas is rated as a Distinguished provider by MediFind in the treatment of Spinal Tumor. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Pleuropulmonary Blastoma, and Lymphofollicular Hyperplasia.

Experienced in Spinal Tumor
Dr. Ebenezer A. Kio
Hematology Oncology | Hematology | Oncology
Experienced in Spinal Tumor
Dr. Ebenezer A. Kio
Hematology Oncology | Hematology | Oncology

University Of Chicago

5841 S Maryland Ave, 
Chicago, IL 
 (7.4 miles away)
773-702-1000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Ebenezer Kio is a Hematologist Oncology specialist and a Hematologist in Chicago, Illinois. Dr. Kio is rated as a Distinguished provider by MediFind in the treatment of Spinal Tumor. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Non-Hodgkin Lymphoma, and Chronic Lymphocytic Leukemia (CLL). Dr. Kio is currently accepting new patients.

Experienced in Spinal Tumor
Dr. Evan P. Pisick
Hematology Oncology | Oncology
Experienced in Spinal Tumor
Dr. Evan P. Pisick
Hematology Oncology | Oncology

City Of Hope Medical Group Of Illinois PLLC

2520 Elisha Ave, 
Zion, IL 
 (39.7 miles away)
847-872-4561
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Evan Pisick is a Hematologist Oncology specialist and an Oncologist in Zion, Illinois. Dr. Pisick is rated as a Distinguished provider by MediFind in the treatment of Spinal Tumor. His top areas of expertise are Familial Prostate Cancer, Lung Cancer, Colorectal Cancer, and Familial Colorectal Cancer. Dr. Pisick is currently accepting new patients.

VIEW MORE SPINAL TUMOR DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Lukas's expertise for a condition
ConditionClose
  • Elite
  • Astrocytoma
    Dr. Lukas is
    Elite
    . Learn about Astrocytoma.
    See more Astrocytoma experts
  • Brain Tumor
    Dr. Lukas is
    Elite
    . Learn about Brain Tumor.
    See more Brain Tumor experts
  • Glioblastoma
    Dr. Lukas is
    Elite
    . Learn about Glioblastoma.
    See more Glioblastoma experts
  • Glioma
    Dr. Lukas is
    Elite
    . Learn about Glioma.
    See more Glioma experts
  • Gliomatosis Cerebri
    Dr. Lukas is
    Elite
    . Learn about Gliomatosis Cerebri.
    See more Gliomatosis Cerebri experts
  • Distinguished
  • Atypical Teratoid Rhabdoid Tumor (ATRT)
    Dr. Lukas is
    Distinguished
    . Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
    See more Atypical Teratoid Rhabdoid Tumor (ATRT) experts
  • Embryonal Tumor with Multilayered Rosettes
    Dr. Lukas is
    Distinguished
    . Learn about Embryonal Tumor with Multilayered Rosettes.
    See more Embryonal Tumor with Multilayered Rosettes experts
  • Ependymoma
    Dr. Lukas is
    Distinguished
    . Learn about Ependymoma.
    See more Ependymoma experts
  • Lung Cancer
    Dr. Lukas is
    Distinguished
    . Learn about Lung Cancer.
    See more Lung Cancer experts
  • Metastatic Brain Tumor
    Dr. Lukas is
    Distinguished
    . Learn about Metastatic Brain Tumor.
    See more Metastatic Brain Tumor experts
  • Neuroepithelioma
    Dr. Lukas is
    Distinguished
    . Learn about Neuroepithelioma.
    See more Neuroepithelioma experts
View All 10 Distinguished Conditions
  • Advanced
  • Brain Stem Cancer
    Dr. Lukas is
    Advanced
    . Learn about Brain Stem Cancer.
    See more Brain Stem Cancer experts
  • Hemangioblastoma
    Dr. Lukas is
    Advanced
    . Learn about Hemangioblastoma.
    See more Hemangioblastoma experts
  • Hypothalamic Hamartomas
    Dr. Lukas is
    Advanced
    . Learn about Hypothalamic Hamartomas.
    See more Hypothalamic Hamartomas experts
  • Inflammatory Myofibroblastic Tumor
    Dr. Lukas is
    Advanced
    . Learn about Inflammatory Myofibroblastic Tumor.
    See more Inflammatory Myofibroblastic Tumor experts
  • Non-Hodgkin Lymphoma
    Dr. Lukas is
    Advanced
    . Learn about Non-Hodgkin Lymphoma.
    See more Non-Hodgkin Lymphoma experts
  • Pineoblastoma
    Dr. Lukas is
    Advanced
    . Learn about Pineoblastoma.
    See more Pineoblastoma experts
View All 10 Advanced Conditions
  • Experienced
  • Adult Soft Tissue Sarcoma
    Dr. Lukas is
    Experienced
    . Learn about Adult Soft Tissue Sarcoma.
    See more Adult Soft Tissue Sarcoma experts
  • ALK-Positive Non-Small Cell Lung Cancer
    Dr. Lukas is
    Experienced
    . Learn about ALK-Positive Non-Small Cell Lung Cancer.
    See more ALK-Positive Non-Small Cell Lung Cancer experts
  • Alveolar Soft Part Sarcoma
    Dr. Lukas is
    Experienced
    . Learn about Alveolar Soft Part Sarcoma.
    See more Alveolar Soft Part Sarcoma experts
  • Bone Tumor
    Dr. Lukas is
    Experienced
    . Learn about Bone Tumor.
    See more Bone Tumor experts
  • Breast Cancer
    Dr. Lukas is
    Experienced
    . Learn about Breast Cancer.
    See more Breast Cancer experts
  • Cerebral Ventricle Cancer
    Dr. Lukas is
    Experienced
    . Learn about Cerebral Ventricle Cancer.
    See more Cerebral Ventricle Cancer experts
View All 54 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.